Prediction of deep myometrial invasion in patients with endometrial cancer:: Clinical utility of contrast-enhanced MR imaging -: A meta-analysis and Bayesian analysis

被引:124
作者
Frei, KA
Kinkel, K
Bonél, HM
Lu, Y
Zaloudek, C
Hricak, H
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
关键词
uterine neoplasms; MR; uterus;
D O I
10.1148/radiology.216.2.r00au17444
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine if, in a patient with an endometrial cancer, in addition to the knowledge of tumor grade, preoperative magnetic resonance (MR) imaging findings contribute to treatment stratification and specialist referral. MATERIALS AND METHODS: By using a MEDLINE literature search and institutional pathology reports, pretest probabilities for myometrial invasion were correlated with tumor grade. Likelihood ratios (LRs) were obtained through summary receiver operating characteristics. RESULTS: The mean pretest probabilities of deep myometrial invasion were derived from seven articles (1,875 patients) and from 125 institutional pathology reports. LRs for the prediction of myometrial invasion with contrast-enhanced MR imaging were derived from nine studies (742 patients); positive and negative LRs were 10.11 and 0.1, respectively. The mean weighted pretest probabilities of deep myometrial invasion in patients with tumor grades 1, 2, or 3 were 13%, 35%, or 54%, respectively. Posttest probabilities of deep myometrial invasion for grades 1, 2, or 3 increased to 60%, 840/0, or 92%, respectively, for positive and decreased to 1%, 5%, or 10%, respectively, for negative MR imaging findings. CONCLUSION: Use of contrast-enhanced MR imaging significantly affects the posttest probability of deep myometrial invasion in patients with all grades of endometrial cancer and could be used to select patients for specialist referral.
引用
收藏
页码:444 / 449
页数:6
相关论文
共 33 条
  • [1] *AM CANC SOC, 1999, CANC FACTS FIG 1999
  • [2] BORONOW RC, 1984, OBSTET GYNECOL, V63, P825
  • [3] Large trials vs meta-analysis of smaller trials - How do their results compare?
    Cappelleri, JC
    Ioannidis, JPA
    Schmid, CH
    deFerranti, SD
    Aubert, M
    Chalmers, TC
    Lau, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (16): : 1332 - 1338
  • [4] CHIANG CL, 1980, INTRO STOCHASTIC PRO, P1
  • [5] CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
  • [6] 2-8
  • [7] INTRAOPERATIVE FROZEN SECTION DIAGNOSIS OF DEPTH OF MYOMETRIAL INVASION IN ENDOMETRIAL ADENOCARCINOMA
    FANNING, J
    TSUKADA, Y
    PIVER, MS
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 37 (01) : 47 - 50
  • [8] SHOULD SELECTIVE PARAAORTIC LYMPHADENECTOMY BE PART OF SURGICAL STAGING FOR ENDOMETRIAL CANCER
    FAUGHT, W
    KREPART, GV
    LOTOCKI, R
    HEYWOOD, M
    [J]. GYNECOLOGIC ONCOLOGY, 1994, 55 (01) : 51 - 55
  • [9] HASUMI K, 1982, CANCER, V50, P904, DOI 10.1002/1097-0142(19820901)50:5<904::AID-CNCR2820500517>3.0.CO
  • [10] 2-V